By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on selling March 2027 CRH puts for income, citing path risk, cyclicality, leverage, construction sector slowdown, and currency translation risks that outweigh the attractive yield boost.
Risk: Synchronized European construction slowdown + U.S. spending taper + leverage amplification in 2026-2027
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The put contract at the $100.00 strike price has a current bid of $7.50. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $100.00, but will also collect the premium, putting the cost basis of the shares at $92.50 (before broker commissions). To an investor already interested in purchasing shares of CRH, that could represent an attractive alternative to paying $105.16/share today.
Because the $100.00 strike represents an approximate 5% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 65%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 7.50% return on the cash commitment, or 11.13% annualized — at Stock Options Channel we call this the *YieldBoost*.
Below is a chart showing the trailing twelve month trading history for CRH plc, and highlighting in green where the $100.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $110.00 strike price has a current bid of $9.70. If an investor was to purchase shares of CRH stock at the current price level of $105.16/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $110.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 13.83% if the stock gets called away at the March 2027 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CRH shares really soar, which is why looking at the trailing twelve month trading history for CRH plc, as well as studying the business fundamentals becomes important. Below is a chart showing CRH's trailing twelve month trading history, with the $110.00 strike highlighted in red:
Considering the fact that the $110.00 strike represents an approximate 5% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 48%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 9.22% boost of extra return to the investor, or 13.69% annualized, which we refer to as the *YieldBoost*.
The implied volatility in the put contract example is 37%, while the implied volatility in the call contract example is 38%.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 251 trading day closing values as well as today's price of $105.16) to be 32%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
### Further CRH Research:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The long-dated options offer only modest edge once realistic downside volatility and construction cyclicality are factored in; the article underplays path risk over 23 months."
The article frames selling the March 2027 $100 put (7.5% YieldBoost, 65% probability of expiring worthless) or a covered call at $110 (9.22% premium, 48% chance of keeping shares) as attractive income strategies for CRH at $105.16. With IV (37-38%) only modestly above realized vol (32%), the premiums look reasonable but not rich. However, March 2027 is 23 months away; the article glosses over path risk, dividend absence, and construction-sector cyclicality. CRH's trailing chart shows it already near highs; any slowdown in U.S. infrastructure or European building activity could easily drive the stock well below $100 well before expiration, turning the '5% discount' put into a much deeper loss.
The strongest case against is that if CRH continues its recent momentum and infrastructure spending stays robust, both the put expires worthless and the covered call delivers 13.8% total return while the stock keeps running — making these conservative strategies unnecessarily limiting upside over nearly two years.
"The multi-year duration of these options exposes investors to excessive macro-cycle risk that the annualized yield figures fail to properly discount."
The article presents a classic 'yield enhancement' play on CRH, focusing on short-dated income via cash-secured puts and covered calls. However, looking at a March 2027 expiration—over two years out—is highly unusual for retail options strategies. This duration introduces significant 'gamma risk' and sensitivity to long-term interest rate shifts and infrastructure spending cycles. While an 11% annualized 'YieldBoost' looks attractive, it ignores the opportunity cost of locking up capital for 24+ months in a volatile building materials sector. Investors are essentially selling long-term volatility at a time when global construction demand is facing cyclical headwinds; the premium may not adequately compensate for the multi-year downside risk.
If CRH continues to benefit from secular tailwinds like the U.S. Infrastructure Investment and Jobs Act, the premium collected effectively lowers the breakeven point, providing a valuable buffer against potential sector-wide multiple compression.
"The elevated implied volatility (37-38%) relative to realized volatility (32%) suggests the options market is pricing in risks the article ignores, and selling downside or capping upside on a cyclical stock near 12-month highs is a yield trap, not an opportunity."
This is a mechanics tutorial dressed as investment advice. CRH (Irish building materials, ~$105) trades near 12-month highs; the article frames put-selling and covered calls as 'attractive alternatives' without addressing why IV is elevated (37-38%) relative to realized vol (32%). That 5-6 point IV premium suggests the market is pricing in material uncertainty—possibly earnings, macro exposure, or sector rotation risk. The 65% probability the $100 put expires worthless sounds reassuring until you realize it means 35% odds CRH drops 5%+ in 24 months. For a cyclical industrial stock, that's not negligible. The article never mentions CRH's leverage, dividend sustainability, or construction cycle exposure.
If CRH is genuinely undervalued and the options market is mispricing tail risk, then selling puts at $92.50 cost basis and collecting 7.5% premium is rational—especially if you wanted to own it anyway. The 13.83% covered call return over 24 months (6.9% annualized) also beats many alternatives in a low-growth environment.
"The option-based YieldBoosts look appealing on paper, but macro-cycle risk, currency sensitivity, dividends, and option liquidity risks can erode or erase those returns."
The piece frames attractive YieldBoosts from March 2027 CRH options, but the math rests on fragile assumptions: (1) long-dated options imply exposure to shifts in implied volatility and macro surprises; (2) the 65% odds of the put expiring worthless assume stable fundamentals and no dividend impact; (3) dividends are ignored, which materially affects total return for a blue-chip like CRH; (4) liquidity and bid-ask dynamics for 5-year options can distort prints; (5) CRH’s exposure to construction cycles and currency translation means downside risk can overwhelm the 7.5% put premium if a downturn hits earnings or cash flows.
The 65% ‘expire worthless’ assumption is just a model; in a real shock CRH could easily move through the strike, and long-dated options can be mispriced as volatility or liquidity deteriorates. Dividends and currency effects also matter and are ignored here.
"CRH leverage turns modest vol into severe put-selling losses on rate spikes nobody quantified."
Claude correctly flags the IV premium as uncertainty pricing, but everyone underweights how CRH's 1.8x net debt/EBITDA leverage amplifies downside in a rates-shock scenario. A 200bp rise in 10-year yields could crush multiples and force the March 2027 $100 put 25-30% in-the-money well before expiry. The 7.5% premium won't offset that path risk.
"The March 2027 options expiration aligns with the expected plateau of US infrastructure spending, making long-dated put selling a poorly timed bet on cyclical exhaustion."
Grok's focus on leverage is critical, but we are ignoring the elephant in the room: the IIJA (Infrastructure Investment and Jobs Act) funding cliff. By 2026, federal infrastructure outlays will likely decelerate, coinciding with the expiration of these options. Selling long-dated puts effectively bets on the duration of a government spending cycle that is already halfway through its peak. We are essentially selling cheap insurance to the market just as systemic macro tailwinds for CRH begin to fade.
"IIJA cliff is real, but CRH's geographic diversification means the put-seller needs a synchronized global construction downturn to lose money—which is plausible but not inevitable by March 2027."
Gemini's IIJA cliff timing is sharp, but the math needs stress-testing. Peak federal infrastructure spend was 2023-2024; by March 2027, we're already in the taper phase. However, CRH's 40% revenue from non-U.S. markets (Europe, Asia) means domestic spending deceleration alone doesn't crater the thesis. The real risk: synchronized European construction slowdown + U.S. taper + Grok's leverage amplification. That's a 2026-2027 convergence risk the 7.5% premium doesn't price.
"FX/currency exposure is the overlooked driver of downside risk for CRH and long-dated option strategies, potentially more than leverage."
Point to Grok on leverage is sensible, but the bigger, overlooked risk is FX/currency translation. CRH derives roughly 40% of revenue outside the U.S., so EUR/USD or GBP/USD moves over the next two years could swing USD earnings and multiples far more than a 200bp rate shock. That cross-border risk isn’t priced into the 7.5% YieldBoost; it could drive meaningful downside even if domestic demand holds steady.
The panel consensus is bearish on selling March 2027 CRH puts for income, citing path risk, cyclicality, leverage, construction sector slowdown, and currency translation risks that outweigh the attractive yield boost.
None identified
Synchronized European construction slowdown + U.S. spending taper + leverage amplification in 2026-2027